Scientists uncover an immunity defence mechanism in patients with Psoriasis

Science is a fascinating thing. All the time, scientists and doctors make medical advances that help to prolong the life of the human race, and make it as healthy as possible. Recently, a skin specific study was carried out in Germany, that may help to relieve symptoms for many sufferers of the persistent skin condition, psoriasis. Though, the researchers surprisingly stumbled upon some game-changing results when they discovered a secret power in our immune systems, an antiviral protein name interleukin-29.

Thousands of people across the States and the EU suffer from skin complaints such as atopic dermatitis (eczema) and psoriasis. For years these complaints have been treated with creams and such, and it is well known that these types of ailments are classed as ‘viral’ infections, meaning that they cannot be treated with anti-biotics and it is up to your body’s immune system to fight the infection.

Researchers at the University of Medicine in Berlin have discovered that patients suffering from atopic dermatitis, produce less anti-viral proteins than patients that are suffering from psoriasis, which means that they have uncovered a new functionality of the immune system. In psoriasis patients, there is a certain type of anti-viral protein produced that is not present in atopic dermatitis patients, called interleukin-29.

The researchers claim that this discovery could help to create new treatments using the interleukin-29 protein, to treat ailments like psoriasis, but also other viral chronic inflammatory diseases, such as certain lung conditions where viral infection is a factor. This is fantastic news for the world of medicine, and even better news in the world of science, showing that the human body will never fail to surprise us.

To read the full article, click the link below: